Share
CNBC Pro

Watch CNBC's full interview with Merck CEO Rob Davis on $11.5 billion Acceleron acquisition

Merck CEO Rob Davis joins CNBC's Meg Tirrell to discuss the company's major acquisition of Acceleron Pharma valued at $11.5 billion and provides an update on Merck's highly anticipated Covid-19 pill.
11:53
Thu, Sep 30 20217:35 AM EDT

watch now
VIDEO06:00
CNBC ProWatch CNBC's full interview with The Leuthold Group's Jim Paulsen and Axonic's Peter Cecchini
watch now
VIDEO05:59
CNBC ProApple, Qualcomm, and PayPal are some of today's top stock picks: Pro Market Movers Dec. 2
watch now
VIDEO05:50
CNBC ProWatch CNBC's full interview with JMP's Mark Lehmann on the pandemic winners
watch now
VIDEO49:54
CNBC ProWatch Thursday's full episode of the Halftime Report — December 2, 2021